Brexit – Pharma: Are you prepared for a “No deal”?

If UK leaves EU without reaching an agreement how will this impact your business? If your business is to supply UK and / or EU with licensed (bio)pharmaceutical products – do you have everything in place for all possible scenarios?

Whatever regulatory and quality-related hurdles await you, Tentamus Pharma services have the solution to get you through the Brexit uncertainty. With dedicated facilities in the UK and several mainland Europe laboratories we can take care of all your analytical dilemmas and challenges – such batch release testing, stability studies, method validation & transfer, bioanalytical services, microbiological and molecular-biological control.

It’s still not too late to start planning your activities.

Give us a call or contact us

 

Tentamus Pharma Group – Brexit Services

 

  • EU / UK Analytical Support of a variety of products and starting materials
  • Small molecules & biologics
  • Compendial methods
  • Analytical Method Transfer (AMT) and Validations
  • Batch Release Services
  • QP Services
  • Regulatory Support / Advice
  • Audits & Quality visits

 

Contact:

 

UK

Larissa Taylor
larissa.taylor@fdas.org
P +44 751 538 33 32

 

EU (Austria)

Dr. Gerald Hofer
gerald.hofer@tentamus.com
P +43 699 131 431 60

 

EU (Germany)

Dr. Jochen Kolb
jochen.kolb@bls-analytik.de
P +49 160 785 58 80

Tentamus laboratories in your vicinity